UNSPSC 51145305: Picilorex

This classification denotes an anorexiant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) S8K2JDR3NZ. European Medicines Agency schedules Picilorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09809MIG. Picilorex generally arises in the molecular formula C14H18CLN.

UNSPSC 51145305 Picilorex is a Commodity code under which state and local governments procure pharmaceutical products and drug management systems, including naloxone, safe drug deactivation systems, and generic multi-source pharmaceuticals and over-the-counter products distributed through established supply chains and cooperative purchasing vehicles. The scope spans both direct procurement of specific pharmaceutical items for community health initiatives and participation in multi-state cooperative pharmaceutical contracts that establish blanket pricing and supply relationships with authorized wholesalers. Issuing bodies include county health departments, state health and human services commissions, and multistate purchasing alliances serving state and local facilities; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) and the Texas Health and Human Services Commission appear as recent active buyers in this space.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries, with all shipping and delivery costs included in vendor proposals and contract awards on a fixed-fee basis with a two-year initial term and one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, exploring direct-contracting models outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Department of Administration's MMCAP issued RFP S1070000015802 on January 20, 2026, due March 26, 2026, to establish multi-award contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson), with pricing weighted 75 percent in evaluation, contract terms effective July 1, 2026, and incumbent amendments extending through June 30, 2028.